« Previous
Next »
Gastroenterology
Volume 132, Issue 1
, Pages
52-65
, January 2007
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
To access this article, please choose from the options below
Supported by a research grant from Abbott Laboratories (Abbott Park, IL).A list of the CHARM study investigators and sites appears in Appendix 1.
PII: S0016-5085(06)02522-4
doi: 10.1053/j.gastro.2006.11.041
© 2007 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 132, Issue 1
, Pages
52-65
, January 2007

